376 related articles for article (PubMed ID: 16791814)
21. Radio-iodine therapy in differentiated thyroid cancer: indications and procedures.
Reiners C; Dietlein M; Luster M
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):989-1007. PubMed ID: 19041827
[TBL] [Abstract][Full Text] [Related]
22. Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I.
Huić D; Medvedec M; Dodig D; Popović S; Ivancević D; Pavlinovic Z; Zuvic M
Nucl Med Commun; 1996 Oct; 17(10):839-42. PubMed ID: 8951903
[TBL] [Abstract][Full Text] [Related]
23. Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer.
Qiu L; Tan H; Yin H; Zhou J; Cheng D; Shi H
Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):313-320. PubMed ID: 30221907
[TBL] [Abstract][Full Text] [Related]
24. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation.
Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T
J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884
[TBL] [Abstract][Full Text] [Related]
25. Recombinant human TSH increases uptake and effective half-life of radioiodine in thyroid hormone secreting metastases of follicular thyroid cancer.
Schneider C; Dietlein M; Eschner W; Schmidt M; Kahraman D; Kobe C
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):160-3. PubMed ID: 22328109
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis, radioiodine and radiotherapy of thyroid carcinomas].
Vosberg H
Praxis (Bern 1994); 1998 Mar; 87(11):376-82. PubMed ID: 9562813
[TBL] [Abstract][Full Text] [Related]
27. Plasma exchanges overcome persistent iodine overload to enable 131I ablation of differentiated thyroid carcinoma.
Toubert ME; Dib-Deperrest A; Houzé P; Parquet N; Hindie E; Moretti JL
Thyroid; 2008 Apr; 18(4):469-72. PubMed ID: 18399770
[TBL] [Abstract][Full Text] [Related]
28. Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer.
Iwano S; Kato K; Nihashi T; Ito S; Tachi Y; Naganawa S
Ann Nucl Med; 2009 Nov; 23(9):777-82. PubMed ID: 19787312
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic 123I and 131I activities and radioiodine therapy. Effects on urinary iodine excretion in patients with differentiated thyroid carcinoma.
Meller B; von Hof K; Genina E; Deisting W; Meller J; Richter E; Baehre M
Nuklearmedizin; 2005; 44(6):243-8. PubMed ID: 16400384
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastases from differentiated thyroid carcinoma: does radioiodine still play a role?
Ronga G; Toteda M; D'Apollo R; De Cristofaro F; Filesi M; Acqualagna G; Argirò R; Ciancamerla M; Ugolini F; Montesano T
Clin Ter; 2012; 163(5):377-81. PubMed ID: 23099964
[TBL] [Abstract][Full Text] [Related]
31. The evolving use of radioiodine therapy in differentiated thyroid cancer.
Mayson SE; Yoo DC; Gopalakrishnan G
Oncology; 2015; 88(4):247-56. PubMed ID: 25503797
[TBL] [Abstract][Full Text] [Related]
32. Dosimetry in the therapy of metastatic differentiated thyroid cancer administering high 131I activity: the experience of Busto Arsizio Hospital (Italy).
Bianchi L; Baroli A; Lomuscio G; Pedrazzini L; Pepe A; Pozzi L; Chiesa C
Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):515-21. PubMed ID: 23358404
[TBL] [Abstract][Full Text] [Related]
33. Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure.
Gabriel S; Farman-Ara B; Bourrelly M; Carpentier O; Sebag F; Palazzo FF; De Micco C; Mancini J; Henry JF; Mundler O; Taïeb D
Nucl Med Commun; 2011 Sep; 32(9):829-33. PubMed ID: 21633315
[TBL] [Abstract][Full Text] [Related]
34. Retro-orbital metastasis from differentiated thyroid carcinoma in a radioiodine therapy-naïve patient: any lesson learned?
Okere PC; Tushar M
Med Princ Pract; 2012; 21(6):579-81. PubMed ID: 22678126
[TBL] [Abstract][Full Text] [Related]
35. Treatment of local and regional recurrences of differentiated thyroid cancer by radio-guided surgery with iodine-131.
Salvatori M; Ardito G; Pelizzo MR; Mariani G; Gross M; Al-Nahhas A; Rubello D
Nucl Med Rev Cent East Eur; 2006; 9(2):119-24. PubMed ID: 17304474
[TBL] [Abstract][Full Text] [Related]
36. Radioiodine accumulation in a large adnexal cystadenofibroma.
Turker O; Dogan I; Kumanlioglu K
Thyroid; 2010 May; 20(5):561-2. PubMed ID: 20406107
[TBL] [Abstract][Full Text] [Related]
37. [Use of 13-cis retinoic acid for treatment of advanced differentiated thyroid cancer].
Handkiewicz-Junak D; Roskosz J; Turska M; Wygoda Z; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():301-6. PubMed ID: 12182039
[TBL] [Abstract][Full Text] [Related]
38. [Effect of radio therapy on the magnitude of iodine radioisotope half-life in the thyroid tissue remnants in patients with differentiated thyroid cancer].
Kozak OV; Trembach OM; Romanenko LV; Butrym OI
Lik Sprava; 2008; (5-6):17-23. PubMed ID: 19253734
[TBL] [Abstract][Full Text] [Related]
39. The epidemiology of thyroid cancer in the Czech Republic in comparison with other countries.
Lukas J; Drabek J; Lukas D; Dusek L; Gatek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):266-75. PubMed ID: 23132514
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer.
Maxon HR; Thomas SR; Samaratunga RC
Thyroid; 1997 Apr; 7(2):183-7. PubMed ID: 9133681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
